Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  2. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  3. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... time to immune reconstitution (including normalization of T, B and natural killer (NK) cell repertoire and Immunoglobulin G production), and to establish the ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  4. T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (MOHEL)

    ... of their disease requires them to receive a stem cell transplant . Stem cells or "mother" cells are the source of ... Unfortunately, there is not a perfectly matched stem cell donor (like a sister or brother) and the subject's disease is considered ...

    Clinical Trial last updated 04/28/2016 - 12:15pm.

  5. Gouldsmith Family Pulls Together for Gabby

    ... pancytopenia , which I fully was expecting. Reno doesn’t have a children’s hospital, but Dr. White has a professional connection to ... noticing Gabby’s symptoms to being prepared for a stem cell transplant was just three weeks. The transplant preparation was ...

    Patient Chronicle last updated 07/06/2017 - 9:40am.

  6. Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

    ... study is to determine a safe dose of BPX-501 gene modified T cells infused after a haplo-identical stem cell transplant to facilitate engraftment and the safety of AP1903 ...

    Clinical Trial last updated 06/13/2016 - 1:54pm.

  7. Advances in antiviral drug cuts infection post SCT

    ... and improves survival in patients undergoing donor stem cell transplant Article Source:  ... of CMV infection in transplant patients that doesn’t produce side effects that negate the benefit of the drug itself, the study ...

    Article last updated 02/23/2017 - 7:26am.

  8. Hematopoietic Stem Cell Transplantation in Aplastic Anemia

    ... How do you currently think about the role of stem cell transplantation in aplastic anemia ? This is an exciting time ... anemia develops into MDS or AML, then outcomes aren’t as good. The survival is lower due to increased treatment-related toxicities ...

    Interview last updated 11/28/2016 - 2:58pm.

  9. Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

    ... lower the risk of the disease coming back after a stem cell transplant in patients with MDS and AML. This study will also be ... between days 60-120 post TCD allogeneic hematopoietic stem cell transplant and up to a year post-transplant or until there is a toxicity ...

    Clinical Trial last updated 04/27/2016 - 1:19pm.

  10. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    ... improved in the group of patients who receive a T-cell replete haploidentical donor hematopoietic cell transplant (HCT) with a ... and study comprehensively immune reconstitution following T-cell replete haploidentical transplantation. ...

    Clinical Trial last updated 05/03/2016 - 11:43am.